Dr. Reddy's Inks Deal To Exit Namenda Pay-For-Delay Suit
By Julia Arciga ( September 1, 2020, 2:48 PM EDT) -- Drug buyers asked a New York federal court on Monday to approve their deal with generic-drug maker Dr. Reddy's Laboratories to settle class allegations accusing the company of conspiring with other pharma firms to keep a generic version of the brand name Alzheimer's drug Namenda off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.